Clinical phenotypes of cardiotoxicity in breast cancer patients undergoing contemporary oncologic therapy
Cardiotoxicity remains a major clinical challenge in breast cancer patients treated with contemporary oncologic therapies, particularly anthracycline-based regimens and HER2-targeted treatments. Although guideline-recommended surveillance strategies are widely implemented, substantial interindividual heterogeneit...